首页> 外国专利> ISOLATED ANTIBODY WHICH BINDS TO THE N-TERMINAL DOMAIN (NTD) OF γ-HRG, IN-VITRO METHODS FOR DETECTING AND PURIFYING γ-HRG USING SUCH ANTIBODY AND USE OF SUCH ANTIBODY IN THE PREPARATION OF MEDICAMENTS

ISOLATED ANTIBODY WHICH BINDS TO THE N-TERMINAL DOMAIN (NTD) OF γ-HRG, IN-VITRO METHODS FOR DETECTING AND PURIFYING γ-HRG USING SUCH ANTIBODY AND USE OF SUCH ANTIBODY IN THE PREPARATION OF MEDICAMENTS

机译:绑定到γ-HRG的N末端域(NTD)的分离抗体,体外方法,用于在药物制备中使用此类抗体和使用此类抗体检测和纯化γ-HRG

摘要

A novel member of the heregulin superfamily has been identified which is designated "gamma-HRG". This molecule, secreted by human breast cancer MDA-MB-175 cells, leads to the formation of a constitutive active receptor complex and stimulates the growth of these cells in an autocrine manner. gamma-HRG polypeptide and nucleic acid are disclosed, together with various uses therefor (e.g. use of gamma-HRG nucleic acid for the recombinant production of gamma-HRG). gamma-HRG antagonists (e.g. neutralizing antibodies and antisense nucleic acid molecules) as well as uses therefor are also described.
机译:已经鉴定出heregulin超家族的一个新成员,称为“γ-HRG”。人乳腺癌MDA-MB-175细胞分泌的这种分子导致组成型活性受体复合物的形成,并以自分泌方式刺激这些细胞的生长。公开了γ-HRG多肽和核酸,以及其各种用途(例如,γ-HRG核酸用于重组生产γ-HRG的用途)。还描述了γ-HRG拮抗剂(例如中和抗体和反义核酸分子)及其用途。

著录项

  • 公开/公告号IL191077B

    专利类型

  • 公开/公告日2011-12-29

    原文格式PDF

  • 申请/专利权人 GENENTECH INC.;

    申请/专利号IL191077

  • 发明设计人

    申请日2008-04-27

  • 分类号G01N33/53;A61K38/00;A61K39/395;A61K48/00;A61P43/00;C07K14/475;C07K14/52;C07K14/71;C07K16/22;C07K19/00;C12N5/06;C12N5/10;C12N15/09;C12N15/12;C12P21/02;C12P21/08;C12Q1/68;

  • 国家 IL

  • 入库时间 2022-08-21 17:24:47

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号